118 related articles for article (PubMed ID: 7053427)
1. Myocardial disposition and cardiac pharmacodynamics of verapamil in the dog.
Keefe DL; Kates RE
J Pharmacol Exp Ther; 1982 Jan; 220(1):91-6. PubMed ID: 7053427
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.
McAllister RG; Bourne DW; Dittert LW
J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818
[TBL] [Abstract][Full Text] [Related]
3. A model to describe myocardial drug disposition in the dog.
Kates RE; Jaillon P
J Pharmacol Exp Ther; 1980 Jul; 214(1):31-6. PubMed ID: 7391969
[TBL] [Abstract][Full Text] [Related]
4. Myocardial disposition of amiodarone in the dog.
Latini R; Connolly SJ; Kates RE
J Pharmacol Exp Ther; 1983 Mar; 224(3):603-8. PubMed ID: 6827483
[TBL] [Abstract][Full Text] [Related]
5. Bupivacaine accentuates the cardiovascular depressant effects of verapamil in conscious dogs.
Edouard A; Froidevaux R; Berdeaux A; Ahmad R; Samii K; Noviant Y
Eur J Anaesthesiol; 1987 Jul; 4(4):249-59. PubMed ID: 3653084
[TBL] [Abstract][Full Text] [Related]
6. The enantiomer-specific kinetics and dynamics of verapamil after rapid intravenous administration to sheep: physiological analysis and modeling.
Huang YF; Upton RN; Zheng D; McLean C; Gray EC; Grant C
J Pharmacol Exp Ther; 1998 Mar; 284(3):1048-57. PubMed ID: 9495866
[TBL] [Abstract][Full Text] [Related]
7. Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart.
Gillis AM; Kates RE
J Pharmacol Exp Ther; 1986 Jun; 237(3):708-12. PubMed ID: 3712276
[TBL] [Abstract][Full Text] [Related]
8. Steady state verapamil tissue distribution in the dog: differing tissue accumulation.
Schwartz JB; Todd E; Abernethy DR; Mitchell JR
Pharmacology; 1986; 32(6):307-12. PubMed ID: 3725887
[TBL] [Abstract][Full Text] [Related]
9. Methoxyflurane anesthesia augments the chronotropic and dromotropic effects of verapamil.
Jamali F; Mayo PR
J Pharm Pharm Sci; 1999; 2(1):30-5. PubMed ID: 10951660
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of intravenous amiodarone in the dog.
Connolly SJ; Latini R; Kates RE
J Cardiovasc Pharmacol; 1984; 6(3):531-5. PubMed ID: 6202982
[TBL] [Abstract][Full Text] [Related]
11. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG
J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984
[TBL] [Abstract][Full Text] [Related]
12. Effects of the T-type Ca(2+) channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue.
Bénardeau A; Weissenburger J; Hondeghem L; Ertel EA
J Pharmacol Exp Ther; 2000 Feb; 292(2):561-75. PubMed ID: 10640293
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the myocardial kinetics of meperidine and its effect on myocardial contractility: model-independent analysis and optimal regional model.
Upton RN; Huang YF; Mather LE; Doolette DJ
J Pharmacol Exp Ther; 1999 Aug; 290(2):694-701. PubMed ID: 10411580
[TBL] [Abstract][Full Text] [Related]
14. [Bioequivalence of generic drugs and substitution: example of depot verapamil].
Rietbrock N; Fischer A; Menke G
Z Kardiol; 1987 Oct; 76(10):621-5. PubMed ID: 3318196
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic-pharmacodynamic model for cardiovascular safety assessment of R1551.
Fleury A; Lavé T; Jonsson F; Schmitt M; Hirkaler G; Polonchuk L; Breidenbach A
J Pharmacol Toxicol Methods; 2011; 63(1):123-33. PubMed ID: 20732434
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
McAllister RG; Kirsten EB
Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cardiovascular actions of CS-611, a new coronary dilator, in the dog.
Motomura S; Satoh K; Yamashita S; Taira N
Arzneimittelforschung; 1981; 31(8):1238-44. PubMed ID: 7197528
[TBL] [Abstract][Full Text] [Related]
18. A two-compartment model for digoxin disposition in dogs.
Kalman SM; Güllner HG; Gibson TA; Kuhn GS; Stinson EB; Miller R; Halpern J
Arzneimittelforschung; 1980; 30(6):943-5. PubMed ID: 7191268
[TBL] [Abstract][Full Text] [Related]
19. Effects of the antihypoxic and neuroprotective drug, lubeluzole, on repolarization phase of canine heart assessed by monophasic action potential recording.
Sugiyama A; Ni C; Arita J; Eto K; Xue YX; Hashimoto K
Toxicol Appl Pharmacol; 1996 Jul; 139(1):109-14. PubMed ID: 8685892
[TBL] [Abstract][Full Text] [Related]
20. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Brenna S; Bonacina E; Vignati S
Fundam Clin Pharmacol; 2004 Dec; 18(6):657-67. PubMed ID: 15548237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
